Back to DA Darsana Capital Partners LP

NVCR

10 quarters

Position history for DADarsana Capital Partners LP's holdings in NovoCure Limited

No. Darsana Capital Partners exited its NVCR (NovoCure) position in Q1 2022. Its Q4 2021 13F listed 258,937 shares worth $19.4M. Darsana Capital Partners held NVCR in 9 quarterly 13F filings before exiting.

Final Value

$0

Final Shares

0

Total Value Change

-$113.8M

Total Shares Change

-1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q1
Latest
Exited
0
-100.0%
$00.0%$82.85
0
2021-Q4
Decreased
258,937
-63.0%
$19.4M0.9%$75.08
0
2021-Q3
Unchanged
700,000
0.0%
$81.3M2.7%$116.17
0
2021-Q2
Increased
700,000
+40.0%
$155.3M4.4%$221.82
77
2021-Q1
Decreased
500,000
-33.3%
$66.1M1.8%$132.18
0
2020-Q4
Decreased
750,000
-43.4%
$129.8M3.7%$173.04
0
2020-Q3
Decreased
1.3M
-22.1%
$147.5M7.5%$111.31
0
2020-Q2
Increased
1.7M
+25.9%
$100.8M6.0%$59.30
75
2020-Q1
Unchanged
1.4M
0.0%
$90.9M4.3%$67.34
0
2019-Q4
First report
1.4M
-
$113.8M3.9%$84.27
0

Other major holders of NVCR: Capital World Investors, FMR LLC, Baillie Gifford & Co., Capital International Investors

Optional analytics helps us improve. How it’s used